Current Funding

  1. R21AI193780-01  Using a Superoxide Dismutase Mimetic to Mitigate Age-Associated, Radiation-Induced Cardiopulmonary Damage: Investigating the Role of Nitro-Oxidative Signaling and Mitochondrial Metabolism
  2. U01 AI184289-01 Sex-dependent Impairment of Nitric Oxide Signaling and Mitochondrial
    Metabolism in Radiation-Induced Cardio-Pulmonary Dysfunction
  3. 1 R21 CA270742-01A1 “Redox manipulation of iron to improve glioblastoma therapy: A phase 1 trial

Past Funding

  1. Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy, Project Number: P01 CA217797
  2. Cancer Center Support Grant (CCSG), Project Number: P30 CA086862
  3. Redox Regulation of Immunological Responses During Cancer Therapy Using Novel Redox Active Molecule Approaches that Both Enhance Anti-Tumor Immune Responses and Limit Normal Tissue Injury
  4. University of Iowa Public-Private Partnership (P3)
  5. Phase 1/2 Study of Stereotactic Body Radiation Therapy (SBRT) with or without GC4711 for Early Stage, Centrally Located or Large Non-Small Cell Lung Cancer (NSCLC), Project Number: GTI-4711-101, Galera Therapeutics, Inc.
  6. A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711 in the Treatment of Unresectable or Borderline Resectable, Nonmetastatic Pancreatic Cancer, Galera Therapeutics, Inc.